Dopamine And NotClaire Ardouin
List of bibliographic references
Number of relevant bibliographic references: 11.Ident. | Authors (with country if any) | Title |
---|---|---|
000221 | Sophie Bayard [France] ; Huan Yu [France, République populaire de Chine] ; Muriel Croisier Langenier [France] ; Bertrand Carlander [France] ; Yves Dauvilliers [France] | Decision making in restless legs syndrome |
000261 | Gabriel Robert [France] ; Dominique Drapier [France] ; Marc Verin [France] ; Bruno Millet [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | Cognitive impulsivity in Parkinson's disease patients: Assessment and pathophysiology |
000304 | Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France] | Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom |
000322 | Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease |
000419 | Tatiana Witjas [France] ; Christelle Baunez [France] ; Jean Marc Henry [France] ; Marie Delfini [France] ; Jean Regis [France] ; André Ali Cherif [France] ; Jean Claude Peragut [France] ; Jean Philippe Azulay [France] | Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation |
000445 | Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
000535 | Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
000583 | Mohamed Jaber [États-Unis, France] ; Sara Jones [États-Unis] ; Bruno Giros [États-Unis] ; Caron [États-Unis] | The dopamine transporter: A crucial component regulating dopamine transmission |
000625 | A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
000657 | Nieoullon [France] ; Lydia Kerkerian-Le Goff [France] | Cellular interactions in the striatum involving neuronal systems using “classical” neurotransmitters: Possible functional implications |
000677 | J. L. Montastruc [France] ; Celsis [France] ; A. Agniel [France] ; J. F. Demonet [France] ; B. Doyon [France] ; M. Puel [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease |
This area was generated with Dilib version V0.6.23. |